pubmed-article:3366926 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:3366926 | lifeskim:mentions | umls-concept:C0026848 | lld:lifeskim |
pubmed-article:3366926 | lifeskim:mentions | umls-concept:C0019764 | lld:lifeskim |
pubmed-article:3366926 | lifeskim:mentions | umls-concept:C0242692 | lld:lifeskim |
pubmed-article:3366926 | lifeskim:mentions | umls-concept:C0085655 | lld:lifeskim |
pubmed-article:3366926 | lifeskim:mentions | umls-concept:C0019630 | lld:lifeskim |
pubmed-article:3366926 | lifeskim:mentions | umls-concept:C1334178 | lld:lifeskim |
pubmed-article:3366926 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
pubmed-article:3366926 | lifeskim:mentions | umls-concept:C2911684 | lld:lifeskim |
pubmed-article:3366926 | lifeskim:mentions | umls-concept:C0185117 | lld:lifeskim |
pubmed-article:3366926 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:3366926 | pubmed:dateCreated | 1988-6-20 | lld:pubmed |
pubmed-article:3366926 | pubmed:abstractText | Muscle biopsy specimens with a pronounced inflammatory component were evaluated for myocyte expression of class II histocompatibility antigens (HLA-DR) by immunohistochemical techniques. All 15 cases of polymyositis were positive; six cases of muscular dystrophy (two Duchenne, four facio-scapulo-humeral), and one case of acute denervation (motor neurone disease) were negative, despite having a comparably intense mononuclear infiltrate. Twelve entirely normal biopsy specimens were also negative for HLA-DR expression. Expression of this membrane glycoprotein may have a clinically important aetiological role in polymyositis, and demonstration of its presence may prove useful as a marker for this disorder in selected problematic biopsy specimens. | lld:pubmed |
pubmed-article:3366926 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3366926 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3366926 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3366926 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3366926 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3366926 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3366926 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3366926 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3366926 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3366926 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3366926 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3366926 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3366926 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3366926 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3366926 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3366926 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3366926 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3366926 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3366926 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3366926 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3366926 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3366926 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3366926 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3366926 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3366926 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3366926 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3366926 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3366926 | pubmed:language | eng | lld:pubmed |
pubmed-article:3366926 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3366926 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:3366926 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3366926 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3366926 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:3366926 | pubmed:month | Apr | lld:pubmed |
pubmed-article:3366926 | pubmed:issn | 0021-9746 | lld:pubmed |
pubmed-article:3366926 | pubmed:author | pubmed-author:FletcherAA | lld:pubmed |
pubmed-article:3366926 | pubmed:author | pubmed-author:SUHS JSJ | lld:pubmed |
pubmed-article:3366926 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:3366926 | pubmed:volume | 41 | lld:pubmed |
pubmed-article:3366926 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:3366926 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:3366926 | pubmed:pagination | 410-4 | lld:pubmed |
pubmed-article:3366926 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
pubmed-article:3366926 | pubmed:meshHeading | pubmed-meshheading:3366926-... | lld:pubmed |
pubmed-article:3366926 | pubmed:meshHeading | pubmed-meshheading:3366926-... | lld:pubmed |
pubmed-article:3366926 | pubmed:meshHeading | pubmed-meshheading:3366926-... | lld:pubmed |
pubmed-article:3366926 | pubmed:meshHeading | pubmed-meshheading:3366926-... | lld:pubmed |
pubmed-article:3366926 | pubmed:meshHeading | pubmed-meshheading:3366926-... | lld:pubmed |
pubmed-article:3366926 | pubmed:meshHeading | pubmed-meshheading:3366926-... | lld:pubmed |
pubmed-article:3366926 | pubmed:meshHeading | pubmed-meshheading:3366926-... | lld:pubmed |
pubmed-article:3366926 | pubmed:meshHeading | pubmed-meshheading:3366926-... | lld:pubmed |
pubmed-article:3366926 | pubmed:year | 1988 | lld:pubmed |
pubmed-article:3366926 | pubmed:articleTitle | Skeletal muscle expression of class II histocompatibility antigens (HLA-DR) in polymyositis and other muscle disorders with an inflammatory infiltrate. | lld:pubmed |
pubmed-article:3366926 | pubmed:affiliation | Department of Histopathology, Leicester Royal Infirmary. | lld:pubmed |
pubmed-article:3366926 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3366926 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3366926 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3366926 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3366926 | lld:pubmed |